| scholarly article | Q13442814 |
| P50 | author | Samia J. Khoury | Q37372486 |
| Raymond A Sobel | Q87841746 | ||
| Vijay Kuchroo | Q87889159 | ||
| P2093 | author name string | Amit Awasthi | |
| Mohamed Oukka | |||
| Terry B Strom | |||
| Valérie Dardalhon | |||
| Wassim Elyaman | |||
| Wenda Gao | |||
| I-Cheng Ho | |||
| George Galileos | |||
| Meike Mitsdoerffer | |||
| Hyoung Kwon | |||
| P2860 | cites work | A novel transcription factor, T-bet, directs Th1 lineage commitment | Q22253874 |
| TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function | Q24314628 | ||
| The biological functions of T helper 17 cell effector cytokines in inflammation | Q24614431 | ||
| Essential role for CD103 in the T cell-mediated regulation of experimental colitis | Q24646106 | ||
| Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
| Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse | Q28589701 | ||
| The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells | Q29614226 | ||
| GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. | Q33312509 | ||
| Th17 cells: effector T cells with inflammatory properties | Q33732092 | ||
| A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice | Q34001680 | ||
| Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis | Q34290627 | ||
| In vivo instruction of suppressor commitment in naive T cells | Q34548023 | ||
| Mast cells are essential intermediaries in regulatory T-cell tolerance | Q34559099 | ||
| Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces | Q34590015 | ||
| IL-10-producing T cells suppress immune responses in anergic tuberculosis patients | Q35159232 | ||
| Control of autoimmunity by naturally arising regulatory CD4+ T cells | Q35623006 | ||
| IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization | Q35757072 | ||
| Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells | Q36156864 | ||
| Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus | Q36364479 | ||
| Tr1 cells: from discovery to their clinical application. | Q36390028 | ||
| Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness | Q36401550 | ||
| T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells | Q36402737 | ||
| Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation | Q36563545 | ||
| Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. | Q37133445 | ||
| Induction and effector functions of T(H)17 cells. | Q37194494 | ||
| Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology | Q39737356 | ||
| Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40) | Q41915051 | ||
| Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice | Q42942093 | ||
| IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages | Q44173170 | ||
| IFN-alpha induces the human IL-10 gene by recruiting both IFN regulatory factor 1 and Stat3. | Q47817002 | ||
| Regulation of T helper cell differentiation by STAT molecules | Q47841624 | ||
| IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. | Q54710076 | ||
| A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. | Q55045567 | ||
| Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 | Q56930023 | ||
| Interleukin-9 is involved in host protective immunity to intestinal nematode infection | Q57194408 | ||
| Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression | Q59048389 | ||
| Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis | Q61779891 | ||
| Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity | Q71120550 | ||
| Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis | Q72526875 | ||
| IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis | Q73869153 | ||
| Inducing and expanding regulatory T cell populations by foreign antigen | Q81392563 | ||
| P2507 | corrigendum / erratum | Erratum: IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ Foxp3− effector T cells | Q57083585 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Forkhead box P3 | Q14865673 |
| Interleukin 4 | Q14865947 | ||
| Interleukin 9 | Q14874546 | ||
| Interleukin 5 | Q14877652 | ||
| Interleukin 13 | Q14878305 | ||
| Transforming growth factor, beta 1 | Q14904616 | ||
| Signal transducer and activator of transcription 6 | Q14914616 | ||
| Interferon gamma | Q21494550 | ||
| Interleukin 17A | Q21495876 | ||
| GATA binding protein 3 | Q21497809 | ||
| Tumor necrosis factor | Q21992447 | ||
| P304 | page(s) | 1347-1355 | |
| P577 | publication date | 2008-11-09 | |
| P1433 | published in | Nature Immunology | Q1071725 |
| P1476 | title | IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells | |
| P478 | volume | 9 |
| Q54933580 | A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease. |
| Q58803375 | A Mechanistic Computational Model Reveals That Plasticity of CD4 T Cell Differentiation Is a Function of Cytokine Composition and Dosage |
| Q55000972 | A Method to In Vitro Differentiate Th9 Cells from Mouse Naïve CD4+ T Cells. |
| Q34168144 | A brief history of IL-9 |
| Q43738079 | A complex issue on CD4(+) T-cell subsets |
| Q59129129 | A conserved enhancer regulates Il9 expression in multiple lineages |
| Q36428081 | A deleterious role for Th9/IL-9 in hepatic fibrogenesis |
| Q36594388 | A gender-related action of IFNbeta-therapy was found in multiple sclerosis. |
| Q42960427 | A gut reaction to IL-9. |
| Q36674426 | A new effect of IL-4 on human γδ T cells: promoting regulatory Vδ1 T cells via IL-10 production and inhibiting function of Vδ2 T cells |
| Q30585550 | A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis. |
| Q39029629 | A review on interleukins: The key manipulators in rheumatoid arthritis |
| Q90929383 | A role for BATF3 in TH9 differentiation and T-cell-driven mucosal pathologies |
| Q41593273 | A vitamin D receptor agonist converts CD4+ T cells to Foxp3+ regulatory T cells in patients with ulcerative colitis |
| Q64897836 | ATP Triggers Human Th9 Cell Differentiation via Nitric Oxide-Mediated mTOR-HIF1α Pathway. |
| Q34495730 | Acquired immune heterogeneity and its sources in human helminth infection. |
| Q24293709 | Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells |
| Q36064611 | Activin A and TGF-β promote T(H)9 cell-mediated pulmonary allergic pathology. |
| Q37800864 | Advances in avian immunology—prospects for disease control: a review |
| Q37357912 | Advances in nutritional research on regulatory T-cells |
| Q37792508 | Advances in transcutaneous vaccine delivery: Do all ways lead to Rome? |
| Q38155907 | Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking |
| Q40540223 | Alkaline Cytosolic pH and High Sodium Hydrogen Exchanger 1 (NHE1) Activity in Th9 Cells. |
| Q51491050 | Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients. |
| Q39441725 | Allergen-Induced IL-6 Regulates IL-9/IL-17A Balance in CD4+ T Cells in Allergic Airway Inflammation |
| Q39402866 | Allergic airway inflammation: key players beyond the Th2 cell pathway. |
| Q35748722 | Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany |
| Q47132488 | Alternative activation generates IL-10 producing type 2 innate lymphoid cells |
| Q82604697 | Alternative lifestyles of T cells |
| Q36853641 | Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis |
| Q64081407 | An Update on Interleukin-9: From Its Cellular Source and Signal Transduction to Its Role in Immunopathogenesis |
| Q34404170 | An animated landscape representation of CD4+ T-cell differentiation, variability, and plasticity: insights into the behavior of populations versus cells |
| Q60997095 | An antitumor boost to TH9 cells |
| Q38586280 | An essential role of the transcription factor GATA-3 for the function of regulatory T cells |
| Q37625553 | An immunological overview of allergen specific immunotherapy -- subcutaneous and sublingual routes |
| Q33435547 | An increased expression profile of Th9/IL-9 correlated with Th17/IL-17 in patients with immune thrombocytopenia |
| Q97905310 | Anti-allergic rhinitis activity of α-lipoic acid via balancing Th17/Treg expression and enhancing Nrf2/HO-1 pathway signaling |
| Q24642507 | Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity |
| Q97093727 | Anticancer effects of the microbiota: how the microbiome shapes the development of IL-9-producing T cells |
| Q28080791 | Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases |
| Q34332508 | Antigen-Specific Th9 Cells Exhibit Uniqueness in Their Kinetics of Cytokine Production and Short Retention at the Inflammatory Site |
| Q39910461 | Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways |
| Q38791725 | Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review |
| Q33604901 | Assessment of the Effects of IL9, IL9R, IL17A, and IL17F Gene Polymorphisms on Women with Allergic Rhinitis in Shahrekord, Iran |
| Q34171756 | Association of mast cell-derived VEGF and proteases in Dengue shock syndrome |
| Q82269020 | Autoimmunity: increasing suspects in the CD4+ T cell lineup |
| Q91496377 | BATF3 is sufficient for the induction of Il9 expression and can compensate for BATF during Th9 cell differentiation |
| Q34033637 | BCL6 controls Th9 cell development by repressing Il9 transcription |
| Q37330271 | CD200R/Foxp3-mediated signalling regulates microglial activation. |
| Q38081174 | CD4(+) T-cell subsets in transplantation |
| Q35025435 | CD4(+)CD62L(+) central memory T cells can be converted to Foxp3(+) T cells |
| Q42726164 | CD4+ T cells, human cytomegalovirus and end-stage renal disease |
| Q37951519 | CD4+ T helper 2 cells--microbial triggers, differentiation requirements and effector functions |
| Q52723272 | CD4+CD25+ T cells expressing FoxP3 in Icelandic horses affected with insect bite hypersensitivity. |
| Q27306067 | CD4+CD25+ regulatory cells contribute to the regulation of colonic Th2 granulomatous pathology caused by schistosome infection |
| Q52659614 | CD96 expression determines the inflammatory potential of IL-9-producing Th9 cells. |
| Q89013284 | CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications |
| Q33796582 | Cancer inflammation and regulatory T cells |
| Q37141380 | Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice |
| Q55236940 | Cell-Intrinsic Roles for Autophagy in Modulating CD4 T Cell Functions. |
| Q37309989 | Cellular sources and immune functions of interleukin-9 |
| Q33725781 | Characteristics of IL-9 induced by Schistosoma japonicum infection in C57BL/6 mouse liver |
| Q38941348 | Characteristics of Schistosoma japonicum infection induced IFN-γ and IL-4 co-expressing plasticity Th cells |
| Q51211082 | Characterization of Th9 Cells in the Development of EAE and IBD. |
| Q58752234 | Characterization of immune responses of human PBMCs infected with Mycobacterium tuberculosis H37Ra: Impact of donor declared BCG vaccination history on immune responses and M. tuberculosis growth |
| Q50113463 | Chitotriosidase inhibits allergic asthmatic airways via regulation of TGF-β expression and Foxp3+ Treg cells |
| Q88618152 | Cholesterol negatively regulates IL-9-producing CD8+ T cell differentiation and antitumor activity |
| Q34073570 | Chronic inflammation and asthma |
| Q40773285 | Circulating T helper 9 cells and increased serum interleukin-9 levels in patients with knee osteoarthritis |
| Q37449413 | Circulating Th22 and Th9 levels in patients with acute coronary syndrome. |
| Q89524724 | Cloning and functional testing of rhesus macaque (Macaca mulatta) IL-9 and IL-33 |
| Q28821869 | Co-expression of the protease furin in Nicotiana benthamiana leads to efficient processing of latent transforming growth factor-β1 into a biologically active protein |
| Q34240220 | Complex interactions of transcription factors in mediating cytokine biology in T cells |
| Q26779956 | Complexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in Tuberculosis |
| Q39500172 | Computational Analysis Supports an Early, Type 17 Cell-Associated Divergence of Blunt Trauma Survival and Mortality |
| Q43494254 | Control of Schistosoma mansoni egg‐induced inflammation by IL‐4‐responsive CD4+CD25−CD103+Foxp3− cells is IL‐10‐dependent |
| Q38108397 | Control of inflammatory heart disease by CD4+ T cells. |
| Q33928472 | Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing Th2-mediated allergic asthma |
| Q36887600 | Costimulator B7-DC attenuates strong Th2 responses induced by Nippostrongylus brasiliensis |
| Q34374026 | Current status of interleukin-10 and regulatory T-cells in cancer |
| Q37929655 | Current understanding of Th2 cell differentiation and function |
| Q42864747 | Cutting edge: Smad2 and Smad4 regulate TGF-β-mediated Il9 gene expression via EZH2 displacement |
| Q33999106 | Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset |
| Q50066647 | CyPA and Emmprin play a role in peri-implantitis |
| Q46099808 | Cyclooxygenase-2 in mucosal DC mediates induction of regulatory T cells in the intestine through suppression of IL-4. |
| Q36999799 | Cyclooxygenase-2 inhibits T helper cell type 9 differentiation during allergic lung inflammation via down-regulation of IL-17RB. |
| Q37981059 | Cytokine pathways in allergic disease |
| Q45825943 | Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg. |
| Q37863274 | Cytokines and effector T cell subsets causing autoimmune CNS disease |
| Q35294461 | Cytokines in autoimmune uveitis |
| Q39660421 | DX5(+)CD4(+) T cells modulate cytokine production by CD4(+) T cells towards IL-10 via the production of IL-4. |
| Q40211036 | Decreased frequency of circulating Th9 cells in patients with chronic hepatitis B infection. |
| Q37166167 | Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells |
| Q51439288 | Defining Epigenetic Regulation of the Interleukin-9 Gene by Chromatin Immunoprecipitation. |
| Q38855580 | Dendritic Cells from Rheumatoid Arthritis Patient Peripheral Blood Induce Th17 Cell Differentiation via miR-363/Integrin αv/TGF-β Axis |
| Q41064020 | Detection of IL-9 producing T cells in the PBMCs of allergic asthmatic patients |
| Q53720740 | Determining the Frequencies of Th9 Cells from Whole Blood. |
| Q37682642 | Development, regulation and functional capacities of Th17 cells |
| Q98612726 | Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn's disease |
| Q34653064 | Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis |
| Q34171286 | Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection |
| Q29614838 | Differentiation of effector CD4 T cell populations (*) |
| Q39023227 | Discovery and initial characterization of Th9 cells: the early years |
| Q35041026 | Disruption of Smad4 expression in T cells leads to IgA nephropathy-like manifestations |
| Q92447462 | Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD |
| Q37039453 | Distinct chemokine receptor axes regulate Th9 cell trafficking to allergic and autoimmune inflammatory sites |
| Q35861776 | Distinct different expression of Th17 and Th9 cells in coxsackie virus B3-induced mice viral myocarditis |
| Q34158278 | Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function. |
| Q47761693 | Diverse continuum of CD4+ T-cell states is determined by hierarchical additive integration of cytokine signals |
| Q33687042 | Diversity and Plasticity of Th Cell Types Predicted from Regulatory Network Modelling |
| Q37065735 | Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity? |
| Q36517178 | Donor-derived exosomes induce specific regulatory T cells to suppress immune inflammation in the allograft heart |
| Q99594209 | Dynamic Roles for IL-2-STAT5 Signaling in Effector and Regulatory CD4+ T Cell Populations |
| Q33830967 | Dynamics of Th9 cells and their potential role in immunopathogenesis of murine schistosomiasis |
| Q37672304 | E3 ubiquitin ligase Cbl-b suppresses proallergic T cell development and allergic airway inflammation |
| Q39724790 | Early oral ovalbumin exposure during maternal milk feeding prevents spontaneous allergic sensitization in allergy-prone rat pups |
| Q51744571 | Ectopically Expressed Membrane-bound Form of IL-9 Exerts Immune-stimulatory Effect on CT26 Colon Carcinoma Cells. |
| Q43554142 | Effect of VIP on the balance between cytokines and master regulators of activated helper T cells |
| Q34754302 | Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. |
| Q55176161 | Effector T Helper Cell Subsets in Inflammatory Bowel Diseases. |
| Q38189119 | Effector and regulatory T cell subsets in diabetes-associated inflammation. Is there a connection with ST2/IL-33 axis? Perspective. |
| Q35084618 | Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation |
| Q37778622 | Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm |
| Q37744925 | Emerging roles of T helper subsets in the pathogenesis of asthma |
| Q35717319 | Eosinophils in glioblastoma biology |
| Q82661628 | Epicutaneous sensitization with protein antigen induces Th9 cells |
| Q83125659 | Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? |
| Q37412329 | Epigenetic mechanisms of regulation of Foxp3 expression |
| Q57083585 | Erratum: IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ Foxp3− effector T cells |
| Q41252379 | Essential role for CCR6 in certain inflammatory diseases demonstrated using specific antagonist and knockin mice |
| Q47134853 | Evidence for Involvement of IL-9 and IL-22 in Cows' Milk Allergy in Infants. |
| Q36799000 | Excessive Th1 responses due to the absence of TGF-β signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis |
| Q41830304 | Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression. |
| Q41170370 | Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease |
| Q35736321 | Expression of T-helper-associated cytokines in patients with type 2 diabetes mellitus with retinopathy. |
| Q91564627 | Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions |
| Q36983081 | Fifty years later: Emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases |
| Q53310088 | Flow Cytometric Assessment of STAT Molecules in Th9 Cells. |
| Q48231647 | Foxo1 Promotes Th9 Cell Differentiation and Airway Allergy |
| Q47669089 | Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of TH9 cells programmed by IL-7. |
| Q57802481 | Foxp3 expression in induced regulatory T cells is stabilized by C/EBP in inflammatory environments |
| Q50962900 | Foxp3+ cells control Th2 responses in a murine model of atopic dermatitis. |
| Q39018591 | Foxp3, Regulatory T Cell, and Autoimmune Diseases |
| Q27008912 | From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines |
| Q37696061 | From bench to bedside: Therapeutic potential of interleukin-9 in the treatment of asthma |
| Q37974922 | From interleukin-9 to T helper 9 cells. |
| Q64230023 | Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines |
| Q43184369 | Functional and Phenotypic Plasticity of CD4(+) T Cell Subsets |
| Q51560833 | Functions of Smad Transcription Factors in TGF-β1-Induced Selectin Ligand Expression on Murine CD4 Th Cells. |
| Q37253949 | Functions of T cells in asthma: more than just T(H)2 cells. |
| Q35484886 | GATA3 controls Foxp3⁺ regulatory T cell fate during inflammation in mice |
| Q33711562 | GATA3: a master of many trades in immune regulation |
| Q36218363 | Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells. |
| Q38491174 | Gene expression profile of the hippocampus of rats subjected to chronic immobilization stress |
| Q48222701 | Germinal-center development of memory B cells driven by IL-9 from follicular helper T cells. |
| Q85913537 | Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells |
| Q38830645 | Green tea EGCG, T-cell function, and T-cell-mediated autoimmune encephalomyelitis |
| Q43905104 | Green tea epigallocatechin-3-gallate modulates differentiation of naïve CD4⁺ T cells into specific lineage effector cells |
| Q48232457 | Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation. |
| Q92259788 | Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion |
| Q57022244 | Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells |
| Q92342000 | Helper T cell differentiation |
| Q34356521 | Helper T cell plasticity: impact of extrinsic and intrinsic signals on transcriptomes and epigenomes |
| Q37942972 | Helper T-cell differentiation and plasticity: insights from epigenetics. |
| Q38202009 | Helper T-cell differentiation in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
| Q36388771 | Heterogeneity and plasticity of T helper cells |
| Q37669449 | Heterogeneity of human effector CD4+ T cells. |
| Q36914741 | Host and microbial factors in regulation of T cells in the intestine |
| Q37176591 | Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease |
| Q37502276 | How diverse--CD4 effector T cells and their functions |
| Q33525560 | Human CD4 memory T cells can become CD4+IL-9+ T cells |
| Q42064754 | Human T cells expressing BEND3 on their surface represent a novel subpopulation that preferentially produces IL-6 and IL-8. |
| Q33915697 | Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity |
| Q38625040 | Human Th2 but not Th9 cells release IL-31 in a STAT6/NF-κB-dependent way. |
| Q61627995 | Human Th9 cells: inflammatory cytokines modulate IL-9 production through the induction of IL-21 |
| Q37398235 | Human Vδ2 T cells are a major source of interleukin-9. |
| Q57792331 | Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation |
| Q42376419 | Human umbilical cord mesenchymal stem cells increase interleukin-9 production of CD4+ T cells |
| Q35637833 | Hyaluronan stimulates ex vivo B lymphocyte chemotaxis and cytokine production in a murine model of fungal allergic asthma |
| Q38844323 | Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis |
| Q37325786 | IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. |
| Q34465276 | IFN-β inhibits the increased expression of IL-9 during experimental autoimmune uveoretinitis |
| Q36417195 | IFN-γ limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27 |
| Q33927028 | IL-10 production by CD4+ effector T cells: a mechanism for self-regulation |
| Q35884991 | IL-10- and TGFβ-mediated Th9 Responses in a Human Helminth Infection |
| Q37809207 | IL-17 family member cytokines: regulation and function in innate immunity. |
| Q41890076 | IL-17 in the rheumatologist's line of sight |
| Q33867538 | IL-1α mediated chorioamnionitis induces depletion of FoxP3+ cells and ileal inflammation in the ovine fetal gut. |
| Q57053348 | IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells |
| Q94484029 | IL-33/ST2/IL-9/IL-9R signaling disrupts ocular surface barrier in allergic inflammation |
| Q40284562 | IL-36γ signaling controls the induced regulatory T cell-Th9 cell balance via NFκB activation and STAT transcription factors. |
| Q64120462 | IL-4 together with IL-1β induces antitumor Th9 cell differentiation in the absence of TGF-β signaling |
| Q37150488 | IL-4-, TGF-β-, and IL-1-dependent expansion of parasite antigen-specific Th9 cells is associated with clinical pathology in human lymphatic filariasis |
| Q39310085 | IL-4: an important cytokine in determining the fate of T cells |
| Q93049869 | IL-9 Exerts Antitumor Effects in Colon Cancer and Transforms the Tumor Microenvironment In Vivo |
| Q89725109 | IL-9 and Th9 Cells in Tumor Immunity |
| Q39454903 | IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology. |
| Q37199828 | IL-9 and Th9 cells: progress and challenges |
| Q43783161 | IL-9 and its receptor are predominantly involved in the pathogenesis of UC. |
| Q37292816 | IL-9 as a mediator of Th17-driven inflammatory disease |
| Q90043719 | IL-9 exerts biological function on antigen-experienced murine T cells and exacerbates colitis induced by adoptive transfer |
| Q37293226 | IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells |
| Q51018344 | IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease. |
| Q36453006 | IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system |
| Q58108127 | IL-9 promotes the pathogenesis of ulcerative colitis through STAT3/SOCS3 signaling |
| Q35002442 | IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis |
| Q38980538 | IL-9 signaling affects central nervous system resident cells during inflammatory stimuli |
| Q83849207 | IL-9(+) IL-10(+) T cells link immediate allergic response to late phase reaction |
| Q37397810 | IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation |
| Q98394811 | IL-9-producing T cells: potential players in allergy and cancer |
| Q39026633 | IL-9-producing cells in the development of IgE-mediated food allergy |
| Q84795718 | IL-9-producing invariant NKT cells protect against DSS-induced colitis in an IL-4-dependent manner |
| Q39287103 | IL-9: Function, Sources, and Detection |
| Q37658504 | IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity |
| Q47139168 | IRF8-dependent molecular complexes control the Th9 transcriptional program. |
| Q36725079 | Identification of the E3 deubiquitinase ubiquitin-specific peptidase 21 (USP21) as a positive regulator of the transcription factor GATA3 |
| Q34629109 | IgE-mediated systemic anaphylaxis and impaired tolerance to food antigens in mice with enhanced IL-4 receptor signaling |
| Q51757389 | Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. |
| Q58735013 | Immune Assisted Tissue Engineering via Incorporation of Macrophages in Cell-Laden Hydrogels Under Cytokine Stimulation |
| Q64946812 | Immune cell subset differentiation and tissue inflammation. |
| Q34007974 | Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells |
| Q37855723 | Immunologic aspects of multiple sclerosis |
| Q84380171 | Immunology's quiet upheaval |
| Q38120159 | Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications. |
| Q27027636 | Immunopathology of inflammatory bowel disease |
| Q41811999 | Immunosuppressive effect of sinomenine in an allergic rhinitis mouse model |
| Q35674703 | Increased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon? |
| Q37733033 | Increased Th9 cells and IL-9 levels accelerate disease progression in experimental atherosclerosis |
| Q33815062 | Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct. |
| Q37706268 | Induction of specific T helper-9 cells to inhibit glioma cell growth |
| Q41863006 | Infectious bursal disease virus influences the transcription of chicken γc and γc family cytokines during infection |
| Q91845769 | Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma |
| Q36064544 | Inhaled house dust mite induces pulmonary T helper 2 cytokine production |
| Q37737820 | Inhibition of squamous cancer growth in a mouse model by Staphylococcal enterotoxin B-triggered Th9 cell expansion |
| Q42477747 | Initial immunological changes as predictors for house dust mite immunotherapy response. |
| Q26764757 | Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer |
| Q37712557 | Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma |
| Q84791007 | Interferon Regulatory Factor 4: Combinational Control of Lymphocyte Differentiation |
| Q36796532 | Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity |
| Q38751334 | Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism. |
| Q37264654 | Interleukin-25 (IL-25) promotes efficient protective immunity against Trichinella spiralis infection by enhancing the antigen-specific IL-9 response |
| Q47189664 | Interleukin-4 Supports the Suppressive Immune Responses Elicited by Regulatory T Cells |
| Q61855679 | Interleukin-6 controls uterine Th9 cells and CD8+ T regulatory cells to accelerate parturition in mice |
| Q35946790 | Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice |
| Q37304072 | Interleukin-9 and T cell subsets |
| Q36639988 | Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. |
| Q37776749 | Interleukin‐9 as a T helper type 17 cytokine |
| Q37245208 | Interruption of dendritic cell-mediated TIM-4 signaling induces regulatory T cells and promotes skin allograft survival |
| Q37600191 | Intestinal effector T cells in health and disease. |
| Q55259683 | Intraperitoneal administration of the anti-IL-23 antibody prevents the establishment of intestinal nematodes in mice. |
| Q34555643 | Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis |
| Q42846660 | Isolation and expansion of human natural T regulatory cells for cellular therapy |
| Q36661584 | Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4 |
| Q90591179 | JAK-STAT pathway targeting for the treatment of inflammatory bowel disease |
| Q89613150 | Janus or Hydra: The Many Faces of T Helper Cells in the Human Tumour Microenvironment |
| Q33853966 | KLF2 is a rate-limiting transcription factor that can be targeted to enhance regulatory T-cell production |
| Q42383187 | Leptin Enhances TH2 and ILC2 Responses in Allergic Airway Disease. |
| Q55279342 | Leptin Promotes Allergic Airway Inflammation through Targeting the Unfolded Protein Response Pathway. |
| Q34489206 | Lineage-specific Effects of 1,25-Dihydroxyvitamin D3 on the Development of Effector CD4 T Cells |
| Q48108959 | Long-term effects: Galectin-1 and specific immunotherapy for allergic responses in the intestine |
| Q35850380 | Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges |
| Q84742904 | Mast cells |
| Q41196294 | Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens |
| Q29027397 | Mechanisms of peripheral tolerance to allergens |
| Q37509047 | Mechanisms of tolerance and allergic sensitization in the airways and the lungs. |
| Q27687830 | Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease |
| Q34412837 | Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus |
| Q52761834 | Messenger RNA Sequencing of Rare Cell Populations in the Lung and Lung-Draining Lymph Nodes. |
| Q92569677 | Metabolic regulation of TH17 cells |
| Q47701375 | MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis |
| Q51712811 | MicroRNAs regulate T-cell production of interleukin-9 and identify hypoxia-inducible factor-2α as an important regulator of T helper 9 and regulatory T-cell differentiation. |
| Q30483471 | Models of autoimmune demyelination in the central nervous system: on the way to translational medicine |
| Q56975174 | Modulation of regulatory T cell-Th17 balance by plasmacytoid dendritic cells |
| Q38203185 | Molecular biology of atopic dermatitis |
| Q30433245 | Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology |
| Q37765944 | Multi-tasking of helper T cells |
| Q34356927 | Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy |
| Q35880106 | Mutated major histocompatibility complex class II transactivator up-regulates interleukin-33-dependent differentiation of Th2 subset through Nod2 binding for NLR (NOD-like receptor) signaling initiation |
| Q36102757 | Mycobacterium vaccae Nebulization Can Protect against Asthma in Balb/c Mice by Regulating Th9 Expression |
| Q37071542 | N-3-(oxododecanoyl)-L-homoserine lactone promotes the induction of regulatory T-cells by preventing human dendritic cell maturation |
| Q34993986 | NFIL3/E4BP4 controls type 2 T helper cell cytokine expression |
| Q34076106 | Natural Foxp3(+) regulatory T cells inhibit Th2 polarization but are biased toward suppression of Th17-driven lung inflammation |
| Q33609040 | Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis |
| Q37621244 | New insights into the differentiation and function of T follicular helper cells. |
| Q33623326 | New insights into the regulation of T cells by gamma(c) family cytokines |
| Q38799600 | New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis |
| Q39442990 | New perspectives on the regulation of type II inflammation in asthma |
| Q84743158 | Nine lives for TH9s? |
| Q37292800 | Nine lives: plasticity among T helper cell subsets |
| Q34037524 | Nitric oxide enhances Th9 cell differentiation and airway inflammation |
| Q35041388 | Nitric oxide modulates TGF-beta-directive signals to suppress Foxp3+ regulatory T cell differentiation and potentiate Th1 development |
| Q42786561 | Nonredundant roles of IL-10 and TGF-β in suppression of immune responses to hepatic AAV-factor IX gene transfer |
| Q36609701 | Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells |
| Q55380934 | Novel strategies in immunotherapy for allergic diseases. |
| Q35939766 | Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation |
| Q37249618 | OX40 signaling favors the induction of T(H)9 cells and airway inflammation |
| Q48351328 | Old and New Lymphocyte Players in Inflammatory Bowel Disease |
| Q33561651 | Once a Treg, always a Treg? |
| Q37628032 | Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression |
| Q47701540 | Orchestration of epithelial-derived cytokines and innate immune cells in allergic airway inflammation. |
| Q33753888 | Organization of proximal signal initiation at the TCR:CD3 complex |
| Q33752778 | Overcoming the hurdles in using mouse genetic models that block TGF-beta signaling |
| Q37027348 | PLZF(+) Innate T Cells Support the TGF-β-Dependent Generation of Activated/Memory-Like Regulatory T Cells |
| Q38665573 | Pathogenic T cell subsets in allergic and chronic inflammatory bowel disorders |
| Q34285649 | Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. |
| Q42333747 | Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients |
| Q41549282 | Peripheral blood Th9 cells reconstitution and its relationship with acute graft-versus-host disease after matched-sibling peripheral blood hematopoietic stem cell transplantation |
| Q37832385 | Phenotypical and functional specialization of FOXP3+ regulatory T cells |
| Q40169229 | Physical attraction of Th9 cells is skin deep |
| Q37509592 | Plasticity of CD4(+) FoxP3(+) T cells |
| Q38310232 | Plasticity of human CD4 T cell subsets |
| Q36702429 | Plasticity within the αβ⁺CD4⁺ T-cell lineage: when, how and what for? |
| Q85759300 | Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis |
| Q92879746 | Potential Mechanisms of T Cell-Mediated and Eosinophil-Independent Bronchial Hyperresponsiveness |
| Q37021660 | Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus |
| Q35523670 | Predisposition to the development of IL-9-secreting T cells in atopic infants |
| Q36837356 | Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity |
| Q41075955 | Programmed death one homolog maintains the pool size of regulatory T cells by promoting their differentiation and stability |
| Q38053810 | Prospects and challenges of using chicken cytokines in disease prevention |
| Q97070167 | Proteome analysis revealed the essential functions of protein phosphatase PP2A in the induction of Th9 cells |
| Q36315992 | Pulmonary Epithelial Cell-Derived Cytokine TGF-β1 Is a Critical Cofactor for Enhanced Innate Lymphoid Cell Function |
| Q37987044 | RORγt-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation |
| Q31132719 | Rapamycin resistant murine th9 cells have a stable in vivo phenotype and inhibit graft-versus-host reactivity |
| Q40204242 | Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4. |
| Q50507569 | Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway. |
| Q43429271 | Recruitment and phenotypic characteristics of interleukin 9-producing CD4+ T cells in malignant pleural effusion |
| Q47845996 | Reducing the Levels of Akt Activation by PDK1 Knock-in Mutation Protects Neuronal Cultures against Synthetic Amyloid-Beta Peptides |
| Q37849438 | Regulating Il9 transcription in T helper cells |
| Q36713986 | Regulation of Foxp3+ inducible regulatory T cell stability by SOCS2 |
| Q33682703 | Regulation of IL-9 expression by IL-25 signaling. |
| Q38979322 | Regulation of Interleukin-10 Expression |
| Q38004975 | Regulation of T helper cell differentiation by interferon regulatory factor family members |
| Q38035601 | Regulation of TGFβ in the immune system: an emerging role for integrins and dendritic cells. |
| Q34953484 | Regulation of human Th9 differentiation by type I interferons and IL-21 |
| Q38105858 | Regulation of innate and adaptive immunity by Notch |
| Q37802427 | Regulation of the Ifng locus in the context of T-lineage specification and plasticity. |
| Q39097028 | Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection |
| Q33860019 | Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6 |
| Q35196374 | Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy |
| Q36064548 | Regulatory T cells in asthma |
| Q38620803 | Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential. |
| Q37728843 | Regulatory T cells: immune suppression and beyond |
| Q48115866 | Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells |
| Q37801396 | Responding to infection and apoptosis — a task for TH17 cells |
| Q36224502 | Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells |
| Q41283266 | Retinoic acid hypersensitivity promotes peripheral tolerance in recent thymic emigrants |
| Q24601213 | Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells |
| Q39157106 | Role of ATP as a Key Signaling Molecule Mediating Radiation-Induced Biological Effects |
| Q37773234 | Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer |
| Q38187410 | Role of IL-9 and STATs in hematological malignancies (Review). |
| Q37729059 | Role of T cells in graft rejection and transplantation tolerance. |
| Q37053851 | Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination |
| Q34023371 | Role of Tyk-2 in Th9 and Th17 cells in allergic asthma |
| Q90225030 | Role of Zinc in Immune System and Anti-Cancer Defense Mechanisms |
| Q38076482 | SMAD regulatory networks construct a balanced immune system |
| Q39121162 | STAT5 and CD4 + T Cell Immunity. |
| Q100307068 | STAT5 promotes accessibility and is required for BATF-mediated plasticity at the Il9 locus |
| Q37076055 | STAT6 controls the number of regulatory T cells in vivo, thereby regulating allergic lung inflammation |
| Q35114346 | STAT6 expression in multiple cell types mediates the cooperative development of allergic airway disease |
| Q35685708 | STAT6-dependent regulation of Th9 development |
| Q49909082 | Selective autophagy restricts IL-9 secretion from TH9 cells: relevance in cancer growth |
| Q41701341 | Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells |
| Q37809744 | Shaping the T-cell repertoire in the periphery |
| Q57054689 | Signal transducer and activator of transcription 4 limits the development of adaptive regulatory T cells |
| Q26778375 | Single-cell technologies to study the immune system |
| Q34742199 | Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival. |
| Q37414801 | Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responses. |
| Q47643463 | Specifically differentiated T cell subset promotes tumor immunity over fatal immunity. |
| Q85167476 | Synergistic Effect of IL-6 and IL-4 in Driving Fate Revision of Natural Foxp3+ Regulatory T Cells |
| Q34793513 | T Cell Activation and Proinflammatory Cytokine Production in Clinically Cured Tuberculosis Are Time-Dependent and Accompanied by Upregulation of IL-10. |
| Q47576343 | T Cell Receptor and Co-Stimulatory Signals for Th9 Generation |
| Q26823613 | T Cells: Soldiers and Spies--The Surveillance and Control of Effector T Cells by Regulatory T Cells |
| Q92634783 | T Helper 9 Cells: A New Player in Immune-Related Diseases |
| Q38245734 | T Helper Cells Fate Mapping by Co-stimulatory Molecules and its Functions in Allograft Rejection and Tolerance |
| Q89860707 | T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis |
| Q28081582 | T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview |
| Q90055083 | T Lymphocyte-Mediated Liver Immunopathology of Schistosomiasis |
| Q42727084 | T cell responses: naive to memory and everything in between |
| Q35558638 | T cell subsets and their signature cytokines in autoimmune and inflammatory diseases |
| Q38134677 | T helper cells plasticity in inflammation. |
| Q34180508 | T regulatory cells control antigen-induced recruitment of mast cell progenitors to the lungs of C57BL/6 mice |
| Q36109798 | T(H)2 heterogeneity: Does function follow form? |
| Q37891668 | T-bet in disease. |
| Q33723154 | T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis |
| Q37902883 | T-helper cells in the etiopathogenesis of periodontal disease: A mini review |
| Q33999342 | TGF-beta and 'adaptive' Foxp3(+) regulatory T cells |
| Q37316137 | TGF-beta can leave you breathless |
| Q34113303 | TGF-beta induces IL-9 production from human Th17 cells. |
| Q33566661 | TGF-β activation and function in immunity |
| Q39408352 | TGF-β and Th17 Cells Related Injuries in Patients with Sulfur Mustard Exposure. |
| Q35903214 | TGF-β converts apoptotic stimuli into the signal for Th9 differentiation |
| Q36458347 | TGF-β in tolerance, development and regulation of immunity |
| Q92480505 | TGF-β induces ST2 and programs ILC2 development |
| Q42702792 | TGF-β induces the expression of the adaptor Ndfip1 to silence IL-4 production during iTreg cell differentiation |
| Q84389025 | TGF-β interactions with IL-1 family members trigger IL-4-independent IL-9 production by mouse CD4(+) T cells |
| Q39094862 | TGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosis |
| Q42973784 | TGF-β1: Mediator of a feedback loop in eosinophilic esophagitis--or should we really say mastocytic esophagitis? |
| Q37967132 | TGF-β: the sword, the wand, and the shield of FOXP3(+) regulatory T cells |
| Q34276027 | TGFβ in T cell biology and tumor immunity: Angel or devil? |
| Q37526777 | TGFβ receptor mutations impose a strong predisposition for human allergic disease |
| Q64103921 | TGFβ-activation by dendritic cells drives Th17 induction and intestinal contractility and augments the expulsion of the parasite Trichinella spiralis in mice |
| Q38107790 | TH2, allergy and group 2 innate lymphoid cells |
| Q37688655 | TH9 cell differentiation, transcriptional control and function in inflammation, autoimmune diseases and cancer. |
| Q37575177 | TH9 cells in anti-tumor immunity |
| Q38948052 | TH9 cells in skin disorders |
| Q56671802 | TH9 cells that express the transcription factor PU.1 drive T cell–mediated colitis via IL-9 receptor signaling in intestinal epithelial cells |
| Q54117525 | TIM‑4 blockade of KCs combined with exogenous TGF‑β injection helps to reverse acute rejection and prolong the survival rate of mice receiving liver allografts. |
| Q61800300 | TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways |
| Q35105613 | Tailored immune responses: novel effector helper T cell subsets in protective immunity |
| Q34157827 | Targeting ganglioside epitope 3G11 on the surface of CD4+ T cells suppresses EAE by altering the Treg/Th17 cell balance |
| Q89628639 | Targeting the IL-9 pathway in cancer immunotherapy |
| Q85741340 | Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation |
| Q33894387 | Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity |
| Q34066077 | Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes |
| Q34146417 | Th17 cells demonstrate stable cytokine production in a proallergic environment |
| Q40594670 | Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome |
| Q89909329 | Th2 cells as an intermediate for the differentiation of naïve T cells into Th9 cells, associated with the Smad3/Smad4 and IRF4 pathway |
| Q37436865 | Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection |
| Q40224197 | Th9 Cells and Parasitic Inflammation: Use of Nippostrongylus and Schistosoma Models |
| Q40224209 | Th9 Cells: New Member of T Helper Cell Family. |
| Q37552040 | Th9 and allergic disease |
| Q39011698 | Th9 and other IL-9-producing cells in allergic asthma |
| Q37259259 | Th9 cell development requires a BATF-regulated transcriptional network |
| Q91771408 | Th9 cells in allergic diseases: A role for the microbiota? |
| Q39006003 | Th9 cells in inflammatory bowel diseases |
| Q39008798 | Th9 cells in the pathogenesis of EAE and multiple sclerosis |
| Q36357944 | Th9 cells promote antitumor immune responses in vivo |
| Q40690742 | Th9 cells: a new population of helper T cells |
| Q37696777 | Th9 cells: differentiation and disease. |
| Q37700776 | Th9/IL-9 profile in human echinococcosis: their involvement in immune response during infection by Echinococcus granulosus |
| Q37835840 | Th9: a new player in asthma pathogenesis? |
| Q58764816 | The -> and -> in the Gene Are Associated With Viral Load and Liver Enzyme Levels in Patients With Chronic Viral Liver Diseases |
| Q50077079 | The Common Cytokine Receptor γ Chain Family of Cytokines |
| Q37215886 | The Current STATus of lymphocyte signaling: new roles for old players. |
| Q50566729 | The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells. |
| Q92857692 | The Endless Saga of Monocyte Diversity |
| Q87405889 | The Escherichia coli heat-labile enterotoxin B subunit protects from allergic airway disease development by inducing CD4+ regulatory T cells |
| Q58090901 | The Foxp3+ regulatory T-cell population requires IL-4Rα signaling to control inflammation during helminth infections |
| Q43246232 | The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses |
| Q38880764 | The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis. |
| Q26799454 | The Newly Identified T Helper 22 Cells Lodge in Leukemia |
| Q41948431 | The Other T Helper Cells in Asthma Pathogenesis |
| Q35680673 | The Profile of T Helper Subsets in Bone Marrow Microenvironment Is Distinct for Different Stages of Acute Myeloid Leukemia Patients and Chemotherapy Partly Ameliorates These Variations |
| Q33593742 | The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases |
| Q26799347 | The TNF-family cytokine TL1A: from lymphocyte costimulator to disease co-conspirator |
| Q41197326 | The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells. |
| Q34312117 | The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin |
| Q36703636 | The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. |
| Q37782213 | The cellular orchestra in skin allergy; are differences to lung and nose relevant? |
| Q28083375 | The development and in vivo function of T helper 9 cells |
| Q37982395 | The deviated balance between regulatory T cell and Th17 in autoimmunity |
| Q37376021 | The different faces of Notch in T-helper-cell differentiation |
| Q56607716 | The dual nature of TH17 cells: shifting the focus to function |
| Q38040749 | The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications |
| Q27001581 | The effects of TLR activation on T-cell development and differentiation |
| Q21131158 | The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome |
| Q37106490 | The expression of inflammatory genes is upregulated in peripheral blood of patients with type 1 diabetes |
| Q38365115 | The immune suppressive function of transforming growth factor-β (TGF-β) in human diseases |
| Q26823691 | The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS) |
| Q53161765 | The many lives of IL-9: a question of survival? |
| Q35490792 | The molecular mechanisms of Foxp3 gene regulation. |
| Q38023601 | The role of costimulatory molecules in directing the functional differentiation of alloreactive T helper cells |
| Q33855162 | The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation. |
| Q37988164 | The symphony of the ninth: the development and function of Th9 cells |
| Q51521238 | The synergistic effect of surface topography and sustained release of TGF-β1 on myogenic differentiation of human mesenchymal stem cells. |
| Q36470838 | The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma. |
| Q38980079 | The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells |
| Q35105032 | The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. |
| Q42230758 | The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-β and suppresses T(H)2 differentiation |
| Q41470945 | The transcription factor musculin promotes the unidirectional development of peripheral Treg cells by suppressing the TH2 transcriptional program |
| Q39006000 | The transcription factor network in Th9 cells |
| Q37830196 | The unexpected link between infection-induced apoptosis and a TH17 immune response. |
| Q35973941 | The unique features of Th9 cells and their products |
| Q37567423 | Therapeutic manipulation of immune tolerance in allergic disease |
| Q41635365 | Therapeutic potential of adipose stem cell-derived conditioned medium against pulmonary hypertension and lung fibrosis. |
| Q39161228 | Thrombospondin immune regulation and the kidney |
| Q86008535 | Thymic stromal lymphopoietin-induced interleukin-17A is involved in the development of IgE-mediated atopic dermatitis-like skin lesions in mice |
| Q37511971 | Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells |
| Q40224202 | Transcription Factor Binding Studies in CD4+ T Cells: siRNA Transfection, Chromatin Immunoprecipitation, and Liquid Luminescent DNA Precipitation Assay |
| Q50669352 | Transcription Factors Downstream of IL-4 and TGF-β Signals: Analysis by Quantitative PCR, Western Blot, and Flow Cytometry. |
| Q42266549 | Transcription factor Foxo1 is essential for IL-9 induction in T helper cells |
| Q55280345 | Transcriptional Control of Th9 Cells: Role of Foxo1 in Interleukin-9 Induction. |
| Q35064355 | Transcriptional and epigenetic networks of helper T and innate lymphoid cells. |
| Q37858466 | Transcriptional regulation by STAT6. |
| Q26823406 | Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling |
| Q53126400 | Transforming growth factor-β, interleukin-17, and IL-23 gene expression profiles associated with human peri-implantitis. |
| Q37780481 | Transgenic mouse models of multiple sclerosis |
| Q37632472 | Translational mini-review series on Th17 cells: CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation |
| Q91526449 | Treg expression of CIS suppresses allergic airway inflammation through antagonizing an autonomous TH2 program |
| Q56474910 | Tregs in immunotherapy: opportunities and challenges |
| Q38530619 | Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system |
| Q38868314 | Tumor-specific Th2 responses inhibit growth of CT26 colon-cancer cells in mice via converting intratumor regulatory T cells to Th9 cells |
| Q35226496 | Type 1 regulatory T cells (Tr1) in autoimmunity |
| Q50558366 | Unlike αβ T cells, γδ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22. |
| Q40104447 | Up-regulation of transient receptor potential vanilloid (TRPV) and down-regulation of brain-derived neurotrophic factor (BDNF) expression in patients with functional dyspepsia (FD). |
| Q34610624 | Vaccination strategies to promote mucosal antibody responses. |
| Q92128397 | What's old is new again: Batf transcription factors and Th9 cells |
| Q52689973 | When worlds collide: Th17 and Treg cells in cancer and autoimmunity. |
| Q61808840 | Yangyin Qingre Huoxue Method in Traditional Chinese Medicine Ameliorates Atherosclerosis in ApoE Mice Suffering from High-Fat Diet and HSP65 Aggression |
| Q42333675 | Yoking OX40 to regulation of IL-9. |
| Q53638799 | [Effector T cells]. |
| Q84542814 | [Th9 cells. Functionally important or just an epiphenomenon?] |
| Q95642020 | miR-145 Inhibits Th9 Cell Differentiation by Suppressing Activation of the PI3K/Akt/mTOR/p70S6K/HIF-1α Pathway in Malignant Ascites from Liver Cancer |
| Q90189626 | ncRNAs in Type-2 Immunity |
| Q35807045 | p-STAT6, PU.1, and NF-κB are involved in allergen-induced late-phase airway inflammation in asthma patients |
| Q49545801 | α4β7+ CD4+ effector/effector memory T cells differentiate into productively and latently infected central memory T cells by TGFβ1 during HIV-1 infection. |
| Q34434443 | γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. |
| Q57083585 | Erratum: IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ Foxp3− effector T cells | main subject | P921 |
Search more.